Canada’s University Health Network said its Toronto Western Hospital would be the first non-US site of a trial for a device created by Neuralink Corp., Elon Musk’s brain-implant company. “We are incredibly proud to be at the forefront of this research advancement in neurosurgery,” UHN Chief Executive Officer Kevin Smith said in an announcement. He also said UHN would be the “first and exclusive” site for the trial in Canada, but did not say when it would begin....